Reaction profile

The FDA adverse-event record for arteritis

13 FDA reports name arteritis, a lower-volume reaction in the CVM extract (VeDDRA 240). Plate stamps and neighbourhood peers follow.

#2346 of 2,481
by report volume (all reactions)
13
reports citing this reaction
76.9%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Arteritis has 13 reports now versus 12 in that prior snapshot: 1 more (8.3%).

Report change
+1
Death-coded reports
+1
Death-coded share
+1.9 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Arteritis changes

FDA AER · VeDDRA plate

Code 240 VOL-TRACE

VOL-TRACE · DEATH-HOT · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 13 reports
  • DEATH-HOT 76.9%
  • BOTTOM-DECILE #2346/2481
  • PHOTO-FINISH Abnormal digital pulse
  • SPECIES-DOG Dog · 11
  • DRUG-LEAD Spinosad · 2
  • DESK-WIDE 11 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Abnormal digital pulse (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Arteritis

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Abnormal digital pulse · near13Acute haemorrhagic pa… · near13Acute jaundice · near13Application site mass… · near13Arteritis · this reaction13Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Arteritis

Arteritis: high death-coded share in the FDA AER plate

Signature read: Arteritis's 76.9% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 13 named reports in the openFDA extract. Death-coded share is upper-third: 10 of 13 reports (76.9% of named reports). Nearest volume peer: Abnormal digital pulse (±0 reports). Lead species Dog (11). Lead co-reported drug Spinosad (2).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 11
Cat 2

Breeds Most Affected

Siberian Husky 2
Chihuahua 2
Retriever - Labrador 1
Domestic Longhair 1
Terrier - Rat 1
Crossbred Canine/dog 1
Boxer (German Boxer) 1
Domestic Shorthair 1
Hound - Basset 1
Beagle 1

Associated Drugs

Spinosad 2
Ivermectin + Pyrantel As Pamoate Salt 2
Maropitant Citrate 2
Bedinvetmab 2
Cephalexin 1
Triamcinolone 1
Chlorhexidine Shampoo 1
Melarsomine Dihydrochloride Injection 1
Fluralaner Chew Tablets 1
Pyrantel Pamoate;Sarolaner 1
Melarsomine Dihydrochloride 1
Selamectin;Sarolaner 1
Recombinant E. Coli Bl21;Recombinant E. Coli Ecl19 1
Unspecified Fluids 1
Benadryl 1
Meloxicam 1
Flea And Tick Preventative 1
Lotilaner 1
Lotilaner,Moxidectin,Praziquantel,Pyrantel Pamoate 1
Capromorelin 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Arteritis (#2346 of 2,481 by report volume); death-coded 76.9%. PlainBreed reaction plate · death-coded share stamp 76.9% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →